Upcoming events on EXAGEN INC. |
|
06/16/22 | | Annual General Meeting |
08/02/22 | | Interim 2022 Earnings Release (Projected) |
11/15/22 | | Q3 2022 Earnings Release (Projected) |
03/29/23 | | FY 2022 Earnings Release (Projected) |
05/10/23 | | Q1 2023 Earnings Release (Projected) |
|
Past events on EXAGEN INC. |
|
05/11/22 | 04:30pm | | Q1 2022 Earnings Call |
05/11/22 | 04:05pm | | Q1 2022 Earnings Release |
05/04/22 | 02:00pm | | Investor Summit Group Interim Conference |
03/23/22 | 02:45pm | | KeyBanc Capital Markets Life Sciences & MedTech Forum |
03/22/22 | 03:30pm | | FY 2021 Earnings Call |
03/22/22 | 03:05pm | | FY 2021 Earnings Release |
02/16/22 | 02:00pm | | BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference - Fireside Chat |
12/01/21 | | Piper Sandler Healthcare Conference |
11/18/21 | 10:30am | | Canaccord Genuity CG MedTech & Diagnostics Forum |
11/10/21 | 04:30pm | | Q3 2021 Earnings Call |
|
Past dividends on EXAGEN INC. |
|
- No events available -
|
|
Fiscal Period : December | 2019 | 2020 | 2021 | 2022 |
Sales M $ |
Released Forecast Spread | 40,4 40,5 -0,36% | 42,0 40,0 5,0% | 48,3 47,3 2,0% | 53,4 |
Operating income (EBITDA) M $ |
Released Forecast Spread | -8,71 -9,50 8,3% | -14,6 -16,3 10% | -23,1 -24,1 4,1% | -32,5 |
Operating profit (EBIT) M $ |
Released Forecast Spread | -9,30 -10,5 12% | -15,2 -16,9 9,9% | -24,1 -25,4 5,3% | -33,5 |
Pre-Tax Profit (EBT) M $ |
Released Forecast Spread | -12,0 -13,8 13% | -16,8 -18,2 7,9% | -26,7 -27,9 4,2% | -35,2 |
Net income M $ |
Released Forecast Spread | -30,3 -13,8 -119% | -16,7 -18,1 8,0% | -26,9 -27,9 3,6% | -35,2 |
EPS $ |
Released Forecast Spread | -8,46 -1,96 -332% | -1,32 -1,43 7,9% | -1,68 -1,74 3,7% | -2,08 | Announcement Date | 03/25/2020 | 03/16/2021 | 03/22/2022 | - |
|
|
Fiscal Period : December | 2020 Q1 | 2020 Q2 | 2020 Q3 | 2020 Q4 | 2021 Q1 | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 |
Sales M $ |
Released Forecast Spread | 9,58 7,73 24% | 8,95 4,67 92% | 10,8 8,81 22% | 12,7 10,7 18% | 10,6 10,5 1,3% | 12,8 11,4 12% | 12,3 12,1 0,97% | 12,7 11,7 8,3% | 10,4 10,0 3,9% | 12,0 | 14,6 | 16,4 | 13,4 | 15,1 |
Operating income (EBITDA) M $ |
Released Forecast Spread | -5,10 -4,55 -12% | -3,29 -7,90 58% | -3,65 -5,40 32% | -2,61 -3,65 29% | -5,38 -5,20 -3,5% | -5,52 -7,10 22% | -6,26 -6,47 3,3% | -5,96 -6,98 15% | -9,40 -9,33 -0,76% | -8,93 | -7,53 | -6,43 | -7,90 | -7,20 |
Operating profit (EBIT) M $ |
Released Forecast Spread | -5,22 -4,65 -12% | -3,42 -9,00 62% | -3,79 -5,38 30% | -2,76 -4,43 38% | -5,57 -5,52 -0,85% | -5,74 -6,75 15% | -6,50 -6,78 4,0% | -6,25 -7,62 18% | -9,68 -9,74 0,63% | -9,08 | -7,78 | -6,92 | -8,85 | -8,05 |
Pre-Tax Profit (EBT) M $ |
Released Forecast Spread | -5,68 -4,30 -32% | -3,36 -9,60 65% | -4,31 -6,07 29% | -3,41 -4,70 27% | -6,21 -5,80 -7,1% | -6,41 -7,03 8,9% | -7,18 -7,40 3,0% | -6,88 -8,05 15% | -10,3 -10,3 0,51% | -9,65 | -8,10 | -7,28 | -9,50 | -8,70 |
Net income M $ |
Released Forecast Spread | -5,56 -4,30 -29% | -3,36 -9,60 65% | -4,31 -6,07 29% | -3,45 -4,73 27% | -6,21 -5,80 -7,1% | -6,41 -7,03 8,9% | -7,18 -7,40 3,0% | -7,05 -8,05 12% | -10,3 -10,3 0,51% | -9,65 | -8,10 | -7,28 | -9,50 | -8,70 |
EPS $ |
Released Forecast Spread | -0,44 -0,34 -29% | -0,27 -0,76 64% | -0,34 -0,48 29% | -0,27 -0,38 29% | -0,48 -0,45 -5,7% | -0,38 -0,43 12% | -0,42 -0,44 4,5% | -0,42 -0,46 9,1% | -0,60 -0,61 1,3% | -0,57 | -0,48 | -0,43 | -0,54 | -0,49 | Announcement Date | 05/11/2020 | 07/28/2020 | 11/10/2020 | 03/16/2021 | 05/11/2021 | 08/09/2021 | 11/10/2021 | 03/22/2022 | 05/11/2022 | - | - | - | - | - | |
|
|
Upcoming sector events for EXAGEN INC. |
|
|
|
Past sector events for EXAGEN INC. |
|
|
|
|
|
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|